Compare KZR & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZR | TCBS |
|---|---|---|
| Founded | 2015 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 49.3M |
| IPO Year | 2018 | 2021 |
| Metric | KZR | TCBS |
|---|---|---|
| Price | $7.39 | $16.80 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 87.5K | 1.6K |
| Earning Date | 05-13-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | 33.33 | ★ 327.27 |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $15.10 |
| 52 Week High | $7.55 | $20.00 |
| Indicator | KZR | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 60.01 | 46.70 |
| Support Level | $7.25 | $16.79 |
| Resistance Level | $7.47 | $17.13 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 75.00 | 62.27 |
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.